scholarly journals A novel method for the multiplexed target enrichment of MinION next generation sequencing libraries using PCR-generated baits

2015 ◽  
Vol 43 (22) ◽  
pp. e152-e152 ◽  
Author(s):  
Timokratis Karamitros ◽  
Gkikas Magiorkinis
2016 ◽  
Vol 16 (3) ◽  
pp. 357-372 ◽  
Author(s):  
Leomar Y. Ballester ◽  
Rajyalakshmi Luthra ◽  
Rashmi Kanagal-Shamanna ◽  
Rajesh R. Singh

2020 ◽  
Vol 13 (1) ◽  
Author(s):  
Peng Peng ◽  
Yanjuan Xu ◽  
Adrian M. Di Bisceglie ◽  
Xiaofeng Fan

Abstract Objective Owing to the overwhelming dominance of human and commensal microbe sequences, low efficiency is a major concern in clinical viral sequencing using next-generation sequencing. DNA composed of 7-deaza-2′-deoxyguanosine 5′-triphosphate (c7dGTP), an analog of deoxyguanosine triphosphate (dGTP), is resistant to selective restriction enzymes. This characteristic has been utilized to develop a novel strategy for target enrichment in next-generation sequencing. Results The new enrichment strategy is named target enrichment via enzymatic digestion in next-generation sequencing (TEEDseq). It combined 7-deaza-2′-deoxyguanosine 5′-triphosphate (c7dGTP)-involved primer extension, splinter-assisted intracellular cyclization, c7dGTP)-resistant enzymatic digestion, and two-phase rolling cycle amplification. We first estimated c7dGTP for its efficiency in PCR amplification and its resistance to three restriction enzymes, AluI, HaeIII, and HpyCH4V. We then evaluated TEEDseq using a serum sample spiked with a 1311-bp hepatitis B virus (HBV) fragment. TEEDseq achieved an HBV on-target rate of 3.31 ± 0.39%, which was equivalent to 454× the enrichment of direct Illumina sequencing. Therefore, the current study has provided a concept proof for TEEDseq as an alternative option for clinical viral sequencing that requires an enrichment in next-generation sequencing.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Jin Sun No ◽  
Won-Keun Kim ◽  
Seungchan Cho ◽  
Seung-Ho Lee ◽  
Jeong-Ah Kim ◽  
...  

Abstract Orthohantaviruses, negative-sense single-strand tripartite RNA viruses, are a global public health threat. In humans, orthohantavirus infection causes hemorrhagic fever with renal syndrome or hantavirus cardiopulmonary syndrome. Whole-genome sequencing of the virus helps in identification and characterization of emerging or re-emerging viruses. Next-generation sequencing (NGS) is a potent method to sequence the viral genome, using molecular enrichment methods, from clinical specimens containing low virus titers. Hence, a comparative study on the target enrichment NGS methods is required for whole-genome sequencing of orthohantavirus in clinical samples. In this study, we used the sequence-independent, single-primer amplification, target capture, and amplicon NGS for whole-genome sequencing of Hantaan orthohantavirus (HTNV) from rodent specimens. We analyzed the coverage of the HTNV genome based on the viral RNA copy number, which is quantified by real-time quantitative PCR. Target capture and amplicon NGS demonstrated a high coverage rate of HTNV in Apodemus agrarius lung tissues containing up to 103–104 copies/μL of HTNV RNA. Furthermore, the amplicon NGS showed a 10-fold (102 copies/μL) higher sensitivity than the target capture NGS. This report provides useful insights into target enrichment NGS for whole-genome sequencing of orthohantaviruses without cultivating the viruses.


2015 ◽  
Vol 76 ◽  
pp. 165
Author(s):  
Hayley Hogan ◽  
Rhys Cransberg ◽  
Megan Jordan ◽  
Damian Goodridge ◽  
David Sayer

2013 ◽  
Vol 15 (12) ◽  
pp. 948-957 ◽  
Author(s):  
Jana Vandrovcova ◽  
Ellen R.A. Thomas ◽  
Santosh S Atanur ◽  
Penny J. Norsworthy ◽  
Clare Neuwirth ◽  
...  

Abstract Purpose: Familial hypercholesterolemia is a common Mendelian disorder associated with early-onset coronary heart disease that can be treated by cholesterol-lowering drugs. The majority of cases in the United Kingdom are currently without a molecular diagnosis, which is partly due to the cost and time associated with standard screening techniques. The main purpose of this study was to test the sensitivity and specificity of two next-generation sequencing protocols for genetic diagnosis of familial hypercholesterolemia. Methods: Libraries were prepared for next-generation sequencing by two target enrichment protocols; one using the SureSelect Target Enrichment System and the other using the PCR-based Access Array platform. Results: In the validation cohort, both protocols showed 100% specificity, whereas the sensitivity for short variant detection was 100% for the SureSelect Target Enrichment and 98% for the Access Array protocol. Large deletions/duplications were only detected using the SureSelect Target Enrichment protocol. In the prospective cohort, the mutation detection rate using the Access Array was highest in patients with clinically definite familial hypercholesterolemia (67%), followed by patients with possible familial hypercholesterolemia (26%). Conclusion: We have shown the potential of target enrichment methods combined with next-generation sequencing for molecular diagnosis of familial hypercholesterolemia. Adopting these assays for patients with suspected familial hypercholesterolemia could improve cost-effectiveness and increase the overall number of patients with a molecular diagnosis. Genet Med 15 12, 948–957.


PLoS ONE ◽  
2013 ◽  
Vol 8 (9) ◽  
pp. e74231 ◽  
Author(s):  
Mark Klinger ◽  
Katherine Kong ◽  
Martin Moorhead ◽  
Li Weng ◽  
Jianbiao Zheng ◽  
...  

2013 ◽  
Vol 24 (2) ◽  
pp. 73-86 ◽  
Author(s):  
K. Bodi ◽  
A. G. Perera ◽  
P. S. Adams ◽  
D. Bintzler ◽  
K. Dewar ◽  
...  

DNA Repair ◽  
2015 ◽  
Vol 26 ◽  
pp. 44-53 ◽  
Author(s):  
Chen-Pang Soong ◽  
Gregory A. Breuer ◽  
Ryan A. Hannon ◽  
Savina D. Kim ◽  
Ahmed F. Salem ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document